This study is in progress, not accepting new patients
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
Summary
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Albireo
- ID
- NCT05035030
- Phase
- Phase 3 Alagille Syndrome Research Study
- Study Type
- Interventional
- Participants
- Expecting 63 study participants
- Last Updated